Peptide directoryBrain, hypothalamus & pituitary

Neuropeptide K

Neurokinin A with a 26-residue extension, a longer-lived tachykinin.

Where it comes from

Made in
Sensory and brain neurons that make the beta splice form of TAC1
Sent out by
With substance P and neurokinin A
Acts on
  • Airway and gut smooth muscle
  • Vessels

What it does

  • Acts like neurokinin A, more slowly and for longer 1
  • Lowers blood pressure when infused into animals, and raises it when given into the brain
  • A tissue form that is cut down to neurokinin A, and cleared from tissue more slowly than the short peptide 3

In medicine

  • No medicine copies it or blocks it; the NK2 blockers trialled in asthma and irritable bowel syndrome act at its receptor 1
  • It is not measured in practice. In research it is separated from neurokinin A by chromatography first, since an antiserum to the shared end of the molecule reads both 2

Beyond the body’s own use

  • Nothing containing it is in trials, approved or obtainable outside the laboratory
  • Its reason for existing is the splice: the beta form of the tachykinin gene puts a 26-residue extension in front of neurokinin A 1, and the product is slower to act and slower to be destroyed 3
  • What is unknown is whether that matters in the body. No animal has been made that can make one splice form and not the other, so nothing shows what a tissue loses when it keeps substance P and loses neuropeptide K 2

Sources

  1. Tatemoto et al., Neuropeptide K, isolation, structure and biological activities of a novel brain tachykinin, Biochemical and Biophysical Research Communications 1985
  2. Takeda et al., Regional distribution of neuropeptide gamma and other tachykinins of the substance P gene, Regulatory Peptides 1990
  3. Michael-Titus et al., In vivo metabolism and clearance of substance P and co-expressed tachykinins in rat striatum, Neuroscience 2002

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.